Can a new injection tame overactive blood cell production?
NCT ID NCT07012109
First seen Aug 18, 2026 · Last updated Aug 18, 2026
Summary
This early-stage trial is testing an investigational drug called BEBT-507 in adults with polycythemia vera, a condition where the body makes too many red blood cells. The study aims to find a safe dose and see if the drug can help control blood cell levels, potentially reducing the need for phlebotomy (blood removal). Participants will receive BEBT-507 as an injection under the skin, and the trial will monitor safety, side effects, and how the drug behaves in the body.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- BEBT-507 injection
- What this could lead to
- If successful, BEBT-507 could offer a new treatment option for people with polycythemia vera who do not respond to or cannot tolerate current therapies, potentially helping to control their condition and reduce the need for blood removal.
- What could go wrong
- This is an early-phase trial, so the drug's safety and effectiveness are not yet established. It may not work as hoped, and there could be side effects. The results will need confirmation in larger studies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYCYTHEMIA VERA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Blood Diseases Hospital, Chinese Academy of Medical Sciences
RECRUITINGTianjin, Tianjin Municipality, 311100, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a hormone mimic curb the need for bloodletting in a blood cancer?
- Can a Dual-Action pill tame bone marrow tumors?
- Can a new drug reduce bloodletting for polycythemia vera?
- A simple Note-Taking change could transform blood cancer care
- Can a new drug help when standard treatment fails for polycythemia vera?
- New drug candidate targets Hard-to-Treat blood cancers